MedPath
NMPA Approval

Diquafosol Sodium Eye Drops

国药准字H20243354

March 19, 2024

Drug Information

地夸磷索钠滴眼液

眼用制剂

3%(5ml:150mg)

化学药品

March 19, 2024

Company Information

Applicant Company

深圳市光明新区凤凰街道汇通路7号万和科技大厦

Manufacturing Company

深圳市光明新区汇通路7号万和科技大厦B、C、D 栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地夸磷索钠滴眼液 - NMPA 批准文号 | MedPath